This inventor holds 25 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Biotechnology Processes. Top assignees: Genentech, Inc., Human Genome Sciences, Inc.. Active years: 2006-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Germantown, MD (US) (2006 - 2009)
- San Ramon, CA (US) (2008 - 2024)
Company Filing History:
Years Active: 2006-2026
Areas of Expertise:
Title: Innovations and Contributions of Michael W. Laird
Introduction
Michael W. Laird, based in San Ramon, California, is an accomplished inventor with a notable portfolio of 23 patents. His inventions primarily focus on advancements in biotechnology, particularly in the production of polypeptides. His work significantly contributes to the realm of recombinant protein production, influencing various applications in the pharmaceutical industry.
Latest Patents
Among his latest innovations, Michael has patented methods for preventing the reduction of disulfide bonds during the recombinant production of polypeptides. This invention addresses the critical issue of safeguarding disulfide bonds while harvesting disulfide-containing polypeptides, including antibodies, from recombinant host cell cultures. His innovative approach ensures enhanced efficiency and quality in the production of therapeutic proteins, making a substantial impact in the field.
Career Highlights
Throughout his career, Michael has made significant strides in the biotechnology sector. He has held key positions at renowned companies, including Genentech, Inc. and Human Genome Sciences, Inc. His work within these organizations has been pivotal in advancing the understanding and application of recombinant DNA technologies.
Collaborations
Michael has collaborated with prominent professionals in the field, including Yung-Hsiang Kao and Melody Trexler Schmidt. These partnerships have fostered innovative developments and have played an essential role in his successful patent applications.
Conclusion
Michael W. Laird’s contributions to biotechnology through his innovative patents demonstrate his commitment to enhancing recombinant protein production techniques. His work not only showcases his ingenuity as an inventor but also positively impacts the future of therapeutic development, ultimately benefiting the pharmaceutical industry and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile